P
PolyPid Ltd. (PYPD)
NCM – Real vaqt narxi. Valyuta: USD
4.56
+0.22 (5.07%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.56
+0.22 (5.07%)
Yopilishda: May 12, 2026, 4:00 PM EDT
PolyPid Ltd. - bu o'ziga xos polimer-lipid inkapsulyatsiya matritsasi (PLEX) texnologiyasidan foydalanib, aniq yo'naltirilgan, mahalliy qo'llaniladigan va uzoq muddat davomida chiqariladigan terapevtik vositalarni ishlab chiqayotgan biofarmatsevtika kompaniyasi bo'lib, qondirilmagan tibbiy ehtiyojlarni qondirishga qaratilgan. Uning asosiy mahsulot nomzodi D-PLEX100 bo'lib, u katta kesmalarga ega qorin bo'shlig'i kolorektal jarrohlikdan o'tgan bemorlarda jarrohlik joyidagi infektsiyalarni (JJI) oldini olish uchun muhim 3-bosqichli tasdiqlovchi sinovda. Kompaniya shuningdek, qattiq o'smalarni davolash uchun preklinik bosqichda bo'lgan OncoPLEXni ham ishlab chiqmoqda. Kompaniya ImmunoGenesis, Inc. bilan qattiq o'smalarni davolash uchun formulalar ishlab chiqish bo'yicha tadqiqot va ishlab chiqish hamkorligiga ega. PolyPid Ltd. 2008 yilda tashkil etilgan va Isroilning Petah Tikva shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jean-Marc Hagai Pharm.D. | Chief Commercial Officer |
| Dr. Nurit Tweezer-Zaks M.B.A., M.D. | Chief Medical Officer |
| Mr. Jonny Missulawin | Chief Financial Officer |
| Mr. Ori Warshavsky | Chief Operating Officer - US |
| Mr. Tal Vilnai | General Counsel & Corporate Secretary |
| Ms. Dalit Hazan | Deputy CEO and Executive VP of R&D, Clinical & Regulatory Affairs |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-31 | 6-K | ea0284288-6k_polypid.htm |
| 2026-02-25 | 20-F | ea0276727-20f_polypid.htm |
| 2026-02-11 | 6-K | ea0276329-6k_polypid.htm |
| 2026-02-04 | 6-K | ea0275322-6k_polypid.htm |
| 2025-12-31 | 6-K | ea0271262-6k_polypid.htm |
| 2025-12-16 | 6-K | ea0269841-6k_polypid.htm |
| 2025-12-03 | 6-K | ea0268313-6k_polypid.htm |
| 2025-11-12 | 6-K | ea0265276-6k_polypid.htm |
| 2025-09-16 | 6-K | ea0257530-6k_polypid.htm |
| 2025-08-13 | S-8 | ea0252816-s8_polypid.htm |
| Ms. Dikla Czaczkes Akselbrad | CEO & Director |
| Ms. Maria Rubin | Executive Vice President of Operations |
| Ms. Rivi Lev-ari | Vice President of Human Resource |